| Domestic Sales | Oncology pharmaceutical formulations including tablets, capsules, injections. | Experience, proprietary oncology formulations, and manufacturing capabilities. | B2B - healthcare providers in India. | Specialized formulations and patented oncology products. | 282 | 78 | Sale of pharmaceutical products to hospitals, clinics, and pharmacies. | Direct sales; volume and contract pricing. | Rising cancer prevalence and new oncology product introductions. | BEEDAN, ADSUNIB, GEM-RTU, ADLEAP, ADLANTE, BEXINIB |
| Export Sales | Export of oncology formulations and APIs. | Regulatory compliance for exports and diversified geographic reach. | B2B - international oncology markets. | Proprietary oncology APIs and export formulations. | 79 | 22 | Product sales to international distributors and healthcare entities. | Contract sales and export pricing. | Expanding global presence and new manufacturing facility in Uzbekistan. | BEEDAN, ADSUNIB |
